Skip to content

A prospective randomized controlled study of remote nutrition management of chronic kidney disease

A prospective randomized controlled study of remote nutrition management of chronic kidney disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012497
Enrollment
Unknown
Registered
2017-08-28
Start date
2017-09-10
Completion date
Unknown
Last updated
2017-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

Experimental observation group:Remote management follow-up with WeChat APP assisted system
control group:Traditional face-to-face follow-up management

Sponsors

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine(Guangdong Provincial Hospital of Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. outpatient or ward patients with first diagnosis from Guangdong Provincial Hospital of Chinese Medicine; 2. Aged 18 ~80 years old; 3. consistent with diagnostic criteria of chronic kidney disease; 4. patients belong to CKD 3-5 after using CKD-EPI formula calculated eGFR with patient's baseline SCR value; 5. informed consent.

Exclusion criteria

Exclusion criteria: 1. immediately need dialysis treatment(Refer to Professor Wang Haiyan editor of "kidney disease (third edition)", where conservative treatment is invalid, the following circumstances should be immediately dialysis: oliguria or anuria for 2 days; uremia symptoms; creatinine clearance rate decreased more than 50 %, Or in the original renal insufficiency based on the creatinine clearance rate decreased by more than 15%; serum potassium = 6.5mmol/L; metabolic acidosis, CO2CP =13mmol/L; pulmonary edema, cerebral edema and other precursors; 2. Severe arrhythmia, acute heart failure, myocardial infarction, acute stroke, unstable angina, NYHA grade IV (New York Heart Association Cardiac Function Rating); 3. combined with acute infectious diseases, active malignant tumors, chronic hepatitis B active and delayed phase, decompensated liver cirrhosis or hematopoietic system and other serious primary disease, diabetes, active tuberculosis or mental illness; 4. GFR fluctuation range =30% within 3 months before enrollment; 5. potassium is higher than the reference range; 6. is known to be allergic or intolerant to a drug in the study; 7. pregnant or lactating patients; 8. patients who are participating in other clinical trials; 9. non-Mongolia race people.

Design outcomes

Primary

MeasureTime frame
End event rate;

Secondary

MeasureTime frame
Biochemical Indicators;Nutritional status;Dietary intake is reasonable;Diet treatment compliance;

Countries

China

Contacts

Public ContactYifan Wu

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine(Guangdong Provincial Hospital of Chinese Medicine)

wuyifan007@163.com+86 13560324448

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026